CMS Proposes Centralized Review, New Standards For Reimbursement Of IDE Studies

Centralized CMS review for Medicare coverage of device studies, as proposed in the 2014 draft physician fee schedule, could make for a more manageable process. But a provision that IDE trials must be designed to show superiority to be “automatically” covered could face industry pushback.

More from Policy & Regulation

More from Medtech Insight